157 related articles for article (PubMed ID: 2743373)
1. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
Hwang YS; Wang JL
Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
[TBL] [Abstract][Full Text] [Related]
2. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
[TBL] [Abstract][Full Text] [Related]
3. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
[TBL] [Abstract][Full Text] [Related]
5. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
[TBL] [Abstract][Full Text] [Related]
6. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography].
Garimoldi M; Pirastu A; Barbanotti G; Sghirinzetti M; Catalano M; Castelfranco M
Minerva Cardioangiol; 1988 Apr; 36(4):159-65. PubMed ID: 3173699
[No Abstract] [Full Text] [Related]
8. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
Sami M; Lisbona R
Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
[TBL] [Abstract][Full Text] [Related]
9. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring.
Gambhir DS; Khalilullah M; Bahl VK
Indian Heart J; 1984; 36(3):142-6. PubMed ID: 6490043
[No Abstract] [Full Text] [Related]
10. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects].
Zacà F; Ghinelli M; Bombardini T; De Collibus C; Zaccaria O; Steffanon L; Azzolini U; Valentini P; Puddu P
G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228
[TBL] [Abstract][Full Text] [Related]
11. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
[TBL] [Abstract][Full Text] [Related]
12. [Ventricular arrhythmias and left ventricular function in coronary artery disease. A study by M-mode echocardiography and 24-hour Holter-monitoring (author's transl)].
Koenig W; Schinz A; Bungeroth KA; Halhuber MJ; Hofmann H; Kollmann G
Z Kardiol; 1981 Mar; 70(3):158-62. PubMed ID: 7234046
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study evaluated by Holter monitoring and by mexiletine serum levels in ventricular arrhythmias].
Meoli P; Sanna GP; Rovelli F
G Ital Cardiol; 1982; 12(2):115-21. PubMed ID: 6757036
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
[TBL] [Abstract][Full Text] [Related]
15. Mexiletine for the treatment of ventricular arrhythmias associated with chronic obstructive pulmonary disease.
Fracalossi C; Ziacchi V; Farisè F; Rossi A; Marino A; Lomanto B; Moretti L
G Ital Cardiol; 1989 Jan; 19(1):46-52. PubMed ID: 2744314
[TBL] [Abstract][Full Text] [Related]
16. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of arrhythmias with high risk of sudden death in chronic Chagas' cardiopathy with oral mexiletine. Evaluation with 24-hour ambulatory electrocardiographic monitoring (Holter)].
Sgammini HO; Evequoz MC; Chuit R; Atti R; Santamarina NO; Kuschnir E
Arq Bras Cardiol; 1983 Feb; 40(2):103-9. PubMed ID: 6354146
[No Abstract] [Full Text] [Related]
19. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
Van Durme JP
Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
[TBL] [Abstract][Full Text] [Related]
20. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group.
Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
